CELG
Celgene Corporation Announces Departure of President and Chief Operating Officer Scott A. Smith
https://www.businesswire.com/news/home/20180402005830/en/
CELG
OTEZLA(R) (Apremilast) Phase III Data Showed Significant Improvements in Patients with Active Behçet's Disease with Oral Ulcers
http://www.businesswire.com/news/home/20180217005007/en/
CELG
Investigational Data Presented at ASCO GI Evaluate ABRAXANE(R) Regimen for Patients with Locally Advanced Pancreatic Cancer
Phase II LAPACT trial results reported on the safety and efficacy of ABRAXANE + gemcitabine induction therapy on tumor burden, disease control, and symptoms
http://www.businesswire.com/news/home/20180119005472/en/
Enhorabuena, los hijos son lo único importante de esta vida.
CELG
Celgene Corporation Announces Preliminary 2017 Unaudited Results and 2018 Financial Guidance
- Preliminary Q4 2017 total revenue of $3.5 billion, a 17 percent increase Y/Y
- Preliminary FY 2017 total revenue of $13.0 billion, a 16 percent increase Y/Y
- Reaffirming 2020 total revenue and adjusted diluted EPS financial targets
http://www.businesswire.com/news/home/20180108006273/en/
CELG
Celgene to Acquire Impact Biomedicines, Adding Fedratinib to Its Pipeline of Novel Therapies for Hematologic Malignancies
Fedratinib is a highly selective JAK2 kinase inhibitor that is being evaluated for myelofibrosis and polycythemia vera
Fedratinib demonstrated clinical improvement in a phase III trial with treatment-naïve myelofibrosis patients and in a phase II trial with myelofibrosis patients resistant or intolerant to ruxolitinib
A New Drug Application (NDA) submission for fedratinib in myelofibrosis is planned for mid-2018
http://www.businesswire.com/news/home/20180107005114/en/
Hola Juan, gracias por tus aportaciones.
Mi impresión es que ese aumento de los aprovisionamietos se debe al material no consumido por la huelga y demas imprevistos. Los pedidos de material se hacen con planificaciones semestrales o anuales y una vez hechos no es fácil retrasar su entrada a fabrica.
Si ese material que ha quedado en el almacen se hubiera metido en producción, el aumento de ventas del semestre podría estar en torno al 20% (número gordo) mas acorde con las cifras de crecimieto del sector y de Lingotes del año pasado.
Lo mismo se puede hacer con el resultado, dando cifras mas razonables.
Por ahora no estoy preocupado y aumentaré la posición si baja de 17€.